Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.
Milojkovic D, Cross NCP, Ali S, Byrne J, Campbell G, Dignan FL, Drummond M, Huntly B, Marshall S, McMullin MF, Neelakantan P, Raghavan M, Sivakumaran M, Tighe J, Wandroo F, Willis F, Glen F, Fildes L, Collington SJ, Ryan J, Clark RE, Mead AJ.
Milojkovic D, et al. Among authors: collington sj.
Br J Haematol. 2021 Jan;192(1):62-74. doi: 10.1111/bjh.16733. Epub 2020 May 24.
Br J Haematol. 2021.
PMID: 32449159
Free article.